Bill Snyder

September 12, 2013

Nobel laureate Beutler to speak at VU Sept. 23

Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall.

By Bill Snyder
September 5, 2013

Discovery Lecture explores brain’s addiction mechanisms

By Bill Snyder
September 5, 2013

‘Simple Beginnings’ ceremony welcomes 98 doctoral students

By Bill Snyder
August 29, 2013

Basic science training grants hit NIH funding ‘grand slam’

When it comes to government funding of basic science training programs for graduate students and postdoctoral fellows, Vanderbilt University Medical Center hit a grand slam this year, officials said.

By Bill Snyder
August 22, 2013

Addiction science expert Volkow to speak Aug. 29

Nora Volkow, M.D., director of the National Institute on Drug Abuse, will begin the 2013-2014 Flexner Discovery Lecture Series next Thursday, Aug. 29, with a discussion of “Advances in Addiction Science.”

By Bill Snyder
August 22, 2013

VU investigators land ‘bridge grants’ from hematology society

Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts.

By Bill Snyder
August 15, 2013

$5.2M NIH grant bolsters colorectal cancer research

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.
By Bill Snyder
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.
By Bill Snyder
August 14, 2013

Oxidative stress in autism

A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care.
By Bill Snyder
August 8, 2013

Nuclear shield against cell death

The protein SARM appears to protect cells from inflammation-driven death by stabilizing the nuclear laminin scaffold.
By Bill Snyder
August 5, 2013

Vanderbilt scientists discover potential new way to treat anxiety

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week.
By Bill Snyder
July 18, 2013

Data management tool developed at VU sees global growth

The number of researchers and institutions worldwide using a Vanderbilt University-developed Web application to collect and manage their data has about doubled in the past year.
By Bill Snyder
1 … 102 103 104 105 106 … 115